Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free CRSP Stock Alerts

CRISPR Therapeutics (CRSP) Short Interest Ratio & Short Volume

CRISPR Therapeutics logo
$59.50 +1.38 (+2.37%)
As of 08/21/2026 04:00 PM Eastern
Compare

CRISPR Therapeutics Short Interest Overview

As of July 31, 2026, CRISPR Therapeutics (CRSP) had a short interest of 18.82 million shares sold short, representing 20.53% of the public float. This marks a -5.01% decrease in short interest since the prior report. The short interest ratio (days to cover) is 11.5, meaning it would take 11.5 days of the average trading volume of 1.52 million shares to cover all short positions.

Current Short Interest
18,815,663 shares
Previous Short Interest
19,808,194 shares
Change Vs. Previous Month
-5.01%
Dollar Volume Sold Short
$902.96 million
Short Interest Ratio
11.5 Days to Cover
Last Record Date
July 31, 2026
Outstanding Shares
96,690,000 shares
Short Percent of Float
20.53%
Today's Trading Volume
2,450,239 shares
Average Trading Volume
1,516,685 shares
Today's Volume Vs. Average
162%
Short Selling CRISPR Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for CRISPR Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

CRSP Short Interest Over Time

CRSP Days to Cover Over Time

CRSP Percentage of Float Shorted Over Time

CRISPR Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202618,815,663 shares $902.96 million -5.0%20.5%11.52 $47.99
7/15/202619,808,194 shares $1.02 billion -2.9%21.7%11.56 $51.37
6/30/202620,397,833 shares $1.11 billion -23.2%22.1%11.65 $54.59
6/15/202626,572,400 shares $1.40 billion +22.6%28.8%16.35 $52.61
5/29/202621,672,640 shares $1.22 billion -20.6%23.4%12.29 $56.10
5/15/202627,293,997 shares $1.32 billion +21.4%29.6%16.54 $48.41
4/30/202622,484,150 shares $1.18 billion -1.2%24.3%11.91 $52.34
4/15/202622,752,661 shares $1.29 billion +0.6%24.7%15.3 $56.76
3/31/202622,618,060 shares $1.08 billion +4.3%24.7%13.23 $47.57
3/13/202621,686,413 shares $1.06 billion +0.6%23.6%7.63 $48.75
2/27/202621,562,457 shares $1.30 billion -4.8%23.4%14.31 $60.14
2/13/202622,638,749 shares $1.20 billion +3.4%24.5%13.21 $53.07
1/30/202621,888,419 shares $1.09 billion +0.7%23.9%12.1 $49.96
1/15/202621,739,501 shares $1.18 billion +3.3%23.8%11.92 $54.12
12/31/202521,051,418 shares $1.10 billion -3.7%23.0%14.19 $52.44
12/15/202521,863,725 shares $1.23 billion -2.5%23.9%12.3 $56.25
11/28/202522,431,985 shares $1.20 billion -3.3%24.5%9.25 $53.63
11/14/202523,186,755 shares $1.22 billion +10.2%25.4%8.57 $52.53
10/31/202521,033,230 shares $1.35 billion -0.1%24.1%9.89 $63.99
10/15/202521,050,000 shares $1.51 billion -1.4%24.1%8.1 $71.82
9/30/202521,350,000 shares $1.38 billion -10.3%N/A7.4 $64.81
9/15/202523,810,000 shares $1.38 billion +7.9%N/A7.6 $57.84
8/31/202522,070,000 shares $1.14 billion -5.3%25.4%7 $51.83
8/15/202523,310,000 shares $1.39 billion -0.6%N/A7.2 $59.73
7/31/202523,450,000 shares $1.32 billion -7.3%26.9%7.5 $56.26
7/15/202525,300,000 shares $1.33 billion -0.9%N/A8.6 $52.73
6/30/202525,540,000 shares $1.24 billion +19.3%30.9%9.4 $48.64
6/15/202521,410,000 shares $885.52 million +4.2%25.9%9.3 $41.36
5/31/202520,540,000 shares $740.26 million -2.5%25.0%9.6 $36.04
5/15/202521,070,000 shares $765.05 million -1.2%25.6%10.5 $36.31
4/30/202521,320,000 shares $824.44 million +2.7%N/A9.4 $38.67
4/15/202520,760,000 shares $808.60 million +1.2%25.2%9.3 $38.95
3/31/202520,510,000 shares $697.96 million +1.0%24.9%9.2 $34.03
3/15/202520,310,000 shares $855.46 million -2.4%24.7%9.7 $42.12
2/28/202520,810,000 shares $913.98 million +2.0%25.3%9.7 $43.92
2/15/202520,410,000 shares $1.01 billion +4.7%24.8%9.5 $49.72
1/31/202519,490,000 shares $810.59 million -4.0%N/A10.1 $41.59
1/15/202520,310,000 shares $792.90 million +6.3%N/A10.8 $39.04
12/31/202419,100,000 shares $751.78 million +5.4%N/A11.4 $39.36
12/15/202418,120,000 shares $793.29 million -0.2%N/A11.6 $43.78
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad)

Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel

11/30/202418,150,000 shares $928.74 million -6.4%N/A12.7 $51.17
11/15/202419,390,000 shares $916.18 million +4.3%N/A14.8 $47.25
10/31/202418,590,000 shares $862.39 million +5.7%N/A16 $46.39
10/15/202417,590,000 shares $845.20 million +0.2%N/A16.1 $48.05
9/30/202417,560,000 shares $824.97 million +0.1%N/A14.9 $46.98
9/15/202417,540,000 shares $858.41 million +0.6%N/A14.7 $48.94
8/31/202417,440,000 shares $832.24 million +1.6%N/A13.8 $47.72
8/15/202417,170,000 shares $838.75 million +4.5%N/A13.1 $48.85
7/31/202416,430,000 shares $941.27 million +1.9%N/A12 $57.29
7/15/202416,120,000 shares $926.26 million +3.0%N/A12 $57.46
6/30/202415,650,000 shares $845.26 million +5.3%N/A11.9 $54.01
6/15/202414,870,000 shares $945.14 million -5.0%N/A11.1 $63.56
5/31/202415,660,000 shares $841.57 million +2.2%N/A12 $53.74
5/15/202415,330,000 shares $873.20 million +5.1%N/A10.9 $56.96
4/30/202414,590,000 shares $773.12 million -1.0%N/A8.5 $52.99
4/15/202414,740,000 shares $865.53 million -0.1%N/A8.5 $58.72
3/31/202414,760,000 shares $1.01 billion +0.3%N/A7.9 $68.16
3/15/202414,720,000 shares $1.07 billion -2.3%N/A7.4 $72.95
2/29/202415,060,000 shares $1.27 billion +1.3%N/A5.8 $84.22
2/15/202414,870,000 shares $1.26 billion -5.5%N/A5.5 $84.48
1/31/202415,740,000 shares $990.83 million -7.6%N/A5.6 $62.95
1/15/202417,040,000 shares $1.09 billion +4.9%N/A5.8 $64.25
12/31/202316,250,000 shares $1.02 billion -6.2%N/A5.9 $62.60
12/15/202317,330,000 shares $1.08 billion +8.8%N/A6.6 $62.08
11/30/202315,930,000 shares $1.06 billion -2.7%N/A7 $66.73
11/15/202316,370,000 shares $920.49 million +17.9%N/A9.6 $56.23
10/31/202313,890,000 shares $540.74 million +2.5%N/A10.9 $38.93
10/15/202313,550,000 shares $600.40 million +3.9%N/A13.3 $44.31
9/30/202313,040,000 shares $591.89 million -5.4%N/A13.4 $45.39
9/15/202313,790,000 shares $697.50 million -2.1%N/A14.6 $50.58
8/31/202314,080,000 shares $704.14 million +5.0%N/A13.7 $50.01
8/15/202313,410,000 shares $652.80 million +10.7%N/A11.9 $48.68
7/31/202312,110,000 shares $694.27 million -1.6%N/A9.5 $57.33
7/15/202312,310,000 shares $700.56 million -2.1%N/A9.8 $56.91
6/30/202312,570,000 shares $705.68 million +0.8%16.6%9.2 $56.14
6/15/202312,470,000 shares $734.98 million +2.3%16.5%9 $58.94
5/31/202312,190,000 shares $780.65 million -1.9%16.1%9.1 $64.04
5/15/202312,430,000 shares $819.76 million -5.8%16.4%9.5 $65.95
4/30/202313,200,000 shares $646.01 million +1.9%17.5%11.1 $48.94
4/15/202312,950,000 shares $651.51 million +2.0%17.2%11.3 $50.31
3/31/202312,700,000 shares $574.42 million +4.3%16.9%12.2 $45.23
3/15/202312,180,000 shares $547.13 million +9.0%16.2%11.3 $44.92
2/28/202311,170,000 shares $550.90 million +9.0%14.8%10 $49.32
2/15/202310,250,000 shares $534.74 million +2.7%13.7%9.4 $52.17
1/31/20239,980,000 shares $509.18 million +1.0%13.3%9.2 $51.02
1/15/20239,880,000 shares $493.41 million -5.7%13.2%9.1 $49.94
12/30/202210,480,000 shares $426.01 million +12.2%14.0%9.9 $40.65
12/15/20229,340,000 shares $443.65 million -16.2%12.4%8.8 $47.50
11/30/202211,140,000 shares $610.36 million -4.3%14.8%10.6 $54.79
11/15/202211,640,000 shares $710.16 million -7.3%15.5%10.8 $61.01
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
10/31/202212,550,000 shares $656.87 million +6.7%16.7%11.4 $52.34
10/15/202211,760,000 shares $635.86 million +1.7%15.7%10.4 $54.07
9/30/202211,560,000 shares $755.45 million +5.8%16.1%9.1 $65.35
9/15/202210,930,000 shares $819.86 million +0.5%15.3%7.5 $75.01
8/31/202210,880,000 shares $708.18 million +1.5%15.2%6 $65.09
8/15/202210,720,000 shares $859.10 million -2.3%15.0%5.7 $80.14
7/31/202210,970,000 shares $822.75 million -4.9%15.4%5.5 $75.00
7/15/202211,530,000 shares $961.49 million +1.9%16.2%5.8 $83.39
6/30/202211,320,000 shares $687.92 million +6.4%15.9%6.1 $60.77
6/15/202210,640,000 shares $666.70 million +4.0%15.0%6.3 $62.66
5/31/202210,230,000 shares $593.85 million -7.2%14.4%7.3 $58.05
5/15/202211,020,000 shares $575.57 million +8.7%15.5%7.7 $52.23
4/30/202210,140,000 shares $503.15 million -2.3%14.3%7.1 $49.62
4/15/202210,380,000 shares $645.53 million +3.3%14.7%6.8 $62.19
3/31/202210,050,000 shares $630.84 million +7.0%14.2%6.2 $62.77
3/15/20229,390,000 shares $563.78 million +2.5%13.3%5.6 $60.04
2/28/20229,160,000 shares $562.15 million +4.9%13.0%5.5 $61.37
2/15/20228,730,000 shares $532.27 million +6.5%12.4%5.2 $60.97
1/31/20228,200,000 shares $522.75 million -4.0%11.8%5 $63.75
1/15/20228,540,000 shares $578.76 million +6.1%N/A0 $67.77
12/31/20218,050,000 shares $610.03 million -1.2%11.6%4.9 $75.78
12/15/20218,150,000 shares $642.79 million +17.4%11.7%5.1 $78.87
11/30/20216,940,000 shares $554.51 million +18.6%10.0%4.8 $79.90
11/15/20215,850,000 shares $497.72 million +4.8%8.4%4.4 $85.08
10/29/20215,580,000 shares $509.62 million +15.8%8.0%4.4 $91.33
10/15/20214,820,000 shares $467.54 million +80.5%6.9%3.8 $97.00
9/30/20212,670,000 shares $298.85 million -15.8%3.8%2.4 $111.93
9/15/20213,170,000 shares $371.71 million +7.1%4.6%2.6 $117.26
8/31/20212,960,000 shares $369.85 million +0.7%4.4%2.4 $124.95

CRSP Short Interest - Frequently Asked Questions

Short interest is the volume of CRISPR Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 18,815,663 shares of CRSP short. 20.53% of CRISPR Therapeutics' shares are currently sold short. Learn More on CRISPR Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRSP shares currently have a short interest ratio of 11.5. Learn More on CRISPR Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.53% of CRISPR Therapeutics' floating shares are currently sold short.

CRISPR Therapeutics saw a drop in short interest in July. As of July 31st, there was short interest totaling 18,815,663 shares, a drop of 5.0% from the previous total of 19,808,194 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

20.53% of CRISPR Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "healthcare" compare to CRISPR Therapeutics: Allogene Therapeutics, Inc. (20.28%), Axsome Therapeutics, Inc. (8.34%), Beam Therapeutics Inc. (23.65%), Editas Medicine, Inc. (24.73%), Moderna, Inc. (13.98%), Intellia Therapeutics, Inc. (32.64%), Vertex Pharmaceuticals Incorporated (1.56%), Genmab A/S Sponsored ADR (1.20%), BridgeBio Pharma, Inc. (13.92%), Ascendis Pharma A/S (9.10%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.50 billion), Invesco QQQ ($50.36 billion), iShares Russell 2000 ETF ($21.20 billion), Western Digital Corporation ($13.40 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($11.46 billion), iShares 20+ Year Treasury Bond ETF ($7.84 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.51 billion), iShares Semiconductor ETF ($6.37 billion), and Financial Select Sector SPDR Fund ($6.34 billion). View all of the most shorted stocks.

Short selling CRSP is an investing strategy that aims to generate trading profit from CRISPR Therapeutics as its price is falling. CRSP shares are trading up $1.38 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for CRISPR Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRSP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRSP, twice per month. The most recent reporting period available is July, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like CRSP:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:CRSP is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/11/2026. FINRA publishes updated short interest twice a month.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel